Background. The prognosis of stage IV gastric cancer is poor with the 5-year survival rate still being about 10%. Methods. We classified 130 patients with
Results. Based on tumor location, metastasis to the para-aortic lymph nodes was more common in upper-third cancer, and that to the hepatoduodenal lymph nodes was more common in lower-third cancer. The survival rate of patients with non-regional lymph node metastasis was better ...
advanced cancer stage. The prognosis varies according to tumor stage , but the overall5-year survival rateis low as the diagnosis is often made late once symptoms progress. Epidemiology Incidence An estimated 27,600 new cases were diagnosed in the US in 2020.[1][2] ...
PURPOSE: The aim of this study was to determine the prognosis of pN3 stage gastric cancer patients after they have undergone curative resection, and we also wanted to identify the prognostic factors according to the clinico-pathologic features. MATERIALS AND METHODS: Between January 2000 and Decembe...
An increasing number of studies indicate that adrenergic signalling plays a fundamental role in chronic stress-induced tumour progression and metastasis. However, its function in gastric cancer (GC) and its potential mechanisms remain unknown. The expres
Gastric cancer (GC) is one of the most common malignancies and the third leading cause of cancer-related deaths worldwide1. Although diagnosis, surgical techniques, and adjuvant therapies for gastric cancer have advanced over the years, the prognosis for stage III and IV GC remains poor2. In ...
Conclusions In patients with curable Stage IV gastric cancer, at least a D2 gastrectomy to reduce the absolute volume of tumor cells, followed by adjuvant chemotherapy, may be essential to improve their prognosis. In incurable cases, aggressive new chemotherapeutic regimens should be the treatment ...
and Taiwan compared upfront D2 surgery followed by CAPOX adjuvant chemotherapy versus D2 gastrectomy alone in patients with stage II-IIIB gastric cancer [26,27]. Adjuvant CAPOX chemotherapy significantly improved both 5-year DFS (68% vs. 53%; HR 0.58; 95% CI, 0.47 to 0.72; P < 0.00...
and Taiwan compared upfront D2 surgery followed by CAPOX adjuvant chemotherapy versus D2 gastrectomy alone in patients with stage II-IIIB gastric cancer [26,27]. Adjuvant CAPOX chemotherapy significantly improved both 5-year DFS (68% vs. 53%; HR 0.58; 95% CI, 0.47 to 0.72; P < 0.00...
The purpose of this study was to investigate the impact of preoperative/postoperative body weight and nutritional status on the prognosis of patients who underwent gastrectomy for stage II/III gastric cancer. Access through your organization Check access to the full text by signing in through your ...